$0.28
+0.01 (+5.02%)
AIM News30 articles
AIM ImmunoTech Surges on Early Pancreatic Cancer Trial Enrollment Completion
AIM ImmunoTech shares surged over 100% after its Phase 2 pancreatic cancer trial reached final enrollment ahead of schedule, with the primary endpoint readout set for December 2026.
GAO Audit Casts Doubt on DOGE Savings Claims, Contractors Rally
A GAO audit reveals over half of DOGE's reported contract savings lack proper documentation, yet federal services stocks rise as contractors report strong funded backlogs.
Apple Reclaims World's Most Valuable Company Title, Market Rewards Capital Discipline
Apple surpasses Nvidia in market cap as investors reward its capital-light strategy and strong cash generation, despite Nvidia's faster revenue growth.
Duke Energy Outages Test North Carolina Rate Case Reliability Claims
Duke Energy outages concentrated in North Carolina test the utility's reliability case ahead of a rate settlement decision. Investors monitor restoration timelines.
Apple Briefly Reclaims World's Most Valuable Company Title as AI Capex Concerns Shift Focus
Apple briefly reclaimed the world's most valuable company title during Friday's tech selloff, outperforming AI peers as investors rotate toward lower-capex AI exposure.
JPMorgan Backs $2.5B Shipbuilding Deal, Aims to Boost Maritime Sector
JPMorgan Chase (JPM) is providing $24 million in funding for a $2.5 billion shipbuilding deal between Rhoads Industries and Electric Boat, a General Dynamics subsidiary.
AI Trading Bot Promises Daily Returns of 4%, Audit Claims Questioned
MoneySimpler's new AI trading bot claims daily returns up to 4%, but missing audit details and regulatory clarity raise investor concerns.
Hardee's Franchisee Bankruptcy Reveals 95% Claim Concentration in Acquisition Debt
Superior Star LLC's bankruptcy reveals 94.6% of its largest unsecured claims are acquisition-related, not trade payables, threatening Hardee's revenue and bond payments.
Deltic Energy Share Discount Widens as AIM Thinness Tests Cash Offer
Deltic Energy shares remain below the 7.7p cash offer from NEO NEXT+, with thin AIM liquidity widening the bid spread. Peel Hunt trades reveal the real market gap.
EchoStar's Dish Bankruptcy Reveals $3.6 Billion Gap in Wireless Claims
EchoStar's Dish DBS Chapter 11 filing reveals a $3.6 billion gap between FCC trust funds and over $6 billion in disputed 5G shutdown claims.
Generate Biomedicines Shares Reclaim IPO Price After Heavy Trading Week
Generate Biomedicines (GENB) surged 13.7% in a week, closing Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as sector momentum lifts biotech stocks.
Intel Jumps on Trump's Apple Chip Partnership Claim
Intel shares surged over 7% premarket to a record $129.84 after Trump said Apple will partner with Intel for US chip design and production, though neither company has confirmed the deal.
Alibaba Shares Tumble 5.4% After Beijing Questions 618 Subsidy Claims
Alibaba's Hong Kong shares plunged 5.4% after Beijing regulators questioned Taobao and Tmall's 618 festival subsidy claims, intensifying regulatory risk and margin worries.
NextEra Energy Aims to Rebound as Dominion Deal and AI-Driven Demand Shape Outlook
NextEra Energy (NEE) ended the week at $87.01, down 0.28%, as its $66.8B acquisition of Dominion Energy remains pending. The deal, which would expand NextEra's PJM footprint, is driven by surging AI-related electricity demand.
Lloyds Banking Group Shares Reclaim 100p Mark After Holiday Session
Lloyds Banking Group shares climbed back above 100p in Tuesday's London session, buoyed by a 33% rise in Q1 pretax profit and ongoing share buybacks.
Nifty 50 Reclaims 24,000 as Crude Plunge Fuels Indian Stock Rally
Indian benchmarks rallied Monday, with the Nifty 50 closing above 24,000 and the Sensex gaining over 1,000 points, as Brent crude fell below $100 on US-Iran peace progress.
UnitedHealth Group Surges on Undervaluation Claims; Trip.com Faces Headwinds
UnitedHealth Group shares show strong momentum with a 20.2% undervaluation, while Trip.com Group dips 3.5% amid valuation debate. Live cattle futures rise on USDA report.
Connecticut Car-Accident Claims Grow More Complex as Medical Costs and Evidence Disputes Rise
Mancini Law says Connecticut car-accident claims are growing more complex as medical treatment, recovery times, and insurance disputes lengthen settlements. State data show traffic deaths fell in 2025, but bicycle and pedestrian fatalities rose.
Bank of America Settles Double-Fee ATM Claims for $2.25M
Bank of America will pay $2.25 million to settle claims it charged customers double out-of-network balance-inquiry fees at 7-Eleven ATMs. Claim deadline is June 29.
Bank of America $2.25M 7-Eleven ATM Fee Settlement: Claim Deadline June 29
Bank of America settles claims of duplicate ATM fees at 7-Eleven for $2.25 million. Former clients have until June 29 to file claims.
Lululemon CEO O'Neill Aims to Counter Skepticism as Proxy Fight Intensifies
Lululemon shares slipped 1.6% as incoming CEO Heidi O'Neill dismissed underestimation claims, while founder Chip Wilson escalates a proxy fight for board seats ahead of the June meeting.
Dow Reclaims 50,000 as AI Rally Hits Yield Headwinds
U.S. stock futures fell Friday after the Dow reclaimed 50,000, as rising Treasury yields and oil prices tempered AI-driven gains. Cisco surged on earnings, with Nvidia and key retailers on deck.
US Retail Sales, Jobless Claims in Focus After Inflation Data Surprise
April retail sales and weekly jobless claims are set for release at 8:30 a.m. EDT, with import-export prices and business inventories also due.
AST SpaceMobile Switches to SpaceX After BlueBird Setback, Aims for Mid-June Launch
AST SpaceMobile will launch three Block 2 BlueBird satellites via SpaceX in mid-June, following the loss of BlueBird 7 on Blue Origin's New Glenn. The company maintains its 2026 rollout target, with shares up nearly 15% to $75.05.
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.
Satoshi Nakamoto Mystery Reignites as Adam Back Challenges New Documentary Claims
Adam Back challenges a new documentary's claims about Satoshi Nakamoto's identity and holdings, as Bitcoin trades near $76,000. The ongoing mystery continues to fuel crypto narratives.
Retiree's $4M S&P 500 Claim Ignites Social Security Debate Ahead of 2033 Trust Fund Depletion
A retiree's assertion that Social Security taxes could have yielded $4M in the S&P 500 reignites debate as the OASI trust fund is projected to run dry by 2033, covering just 77% of benefits.
Hoskinson: XRP Holders Lack Claim to Ripple's Corporate Gains as Cardano Advances DeFi Integration
Charles Hoskinson clarifies that XRP ownership does not grant rights to Ripple's corporate profits, even as Cardano continues developing its plan to incorporate XRP into its decentralized finance infrastructure.
Boeing Unveils New Satellite Platform, Aims for 26 Deliveries in 2026
Boeing and its Millennium subsidiary introduced the Resolute mid-class satellite platform, with plans to deliver 26 spacecraft in 2026. The move responds to urgent military demands for faster production.
Bitcoin Reclaims $75K on ETF Inflows, Easing Oil Prices
Bitcoin climbed above $75,000 Tuesday, erasing weekend losses, fueled by renewed ETF inflows and a drop in oil prices. Major institutions like Morgan Stanley are launching new crypto products.